dalteparin has been researched along with Colonic Neoplasms in 10 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of a patient with carcinoid metastases in the liver is discussed." | 1.31 | Targeted chemoembolization of tumors with poly(2-hydroxyethyl methacrylate) particles. ( Adamyan, A; Gumargalieva, K; Guseinov, E; Horák, D; Kokov, L; Skuba, N; Tchjao, A; Titova, M; Trostenyuk, N; Tsvirkun, V; Vishnevskii, V, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagy, Z | 1 |
| Turcsik, V | 1 |
| Blaskó, G | 1 |
| Hoe, V | 1 |
| Kinnear, N | 1 |
| Christidis, D | 1 |
| O'Connell, H | 1 |
| Trepanier, M | 1 |
| Alhassan, N | 1 |
| Sabapathy, CA | 1 |
| Liberman, AS | 1 |
| Charlebois, P | 1 |
| Stein, BL | 1 |
| S Feldman, L | 1 |
| Lee, L | 1 |
| Djaafar, S | 1 |
| Dunand-Sautier, I | 1 |
| Gonelle-Gispert, C | 1 |
| Lacotte, S | 1 |
| DE Agostini, A | 1 |
| Petro, M | 1 |
| Rubbia-Brandt, L | 1 |
| Morel, P | 1 |
| Toso, C | 1 |
| Mentha, G | 1 |
| Nwachukwu, U | 1 |
| Zacharski, LR | 1 |
| Haines, ST | 1 |
| Dager, WE | 1 |
| Trujillo, TC | 1 |
| Horák, D | 1 |
| Guseinov, E | 1 |
| Vishnevskii, V | 1 |
| Adamyan, A | 1 |
| Kokov, L | 1 |
| Tsvirkun, V | 1 |
| Tchjao, A | 1 |
| Titova, M | 1 |
| Skuba, N | 1 |
| Trostenyuk, N | 1 |
| Gumargalieva, K | 1 |
| Auer, R | 1 |
| Scheer, A | 1 |
| Wells, PS | 1 |
| Boushey, R | 1 |
| Asmis, T | 1 |
| Jonker, D | 1 |
| Carrier, M | 1 |
| Mousa, SA | 1 |
| Mohamed, S | 1 |
2 trials available for dalteparin and Colonic Neoplasms
| Article | Year |
|---|---|
The effect of LMWH (Nadroparin) on tumor progression.
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; | 2009 |
The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer: a pilot randomized controlled trial.
Topics: Adenocarcinoma; Aged; Canada; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule | 2011 |
8 other studies available for dalteparin and Colonic Neoplasms
| Article | Year |
|---|---|
Rectus sheath haematoma causing ureteric obstruction.
Topics: Adenocarcinoma; Aged, 80 and over; Anticoagulants; Colonic Neoplasms; Enoxaparin; Female; Gastrointe | 2018 |
Cost-Effectiveness of Extended Thromboprophylaxis in Patients Undergoing Colorectal Surgery from a Canadian Health Care System Perspective.
Topics: Anticoagulants; Chemoprevention; Colectomy; Colonic Neoplasms; Cost-Benefit Analysis; Decision Suppo | 2019 |
Enoxaparin Attenuates Mouse Colon Cancer Liver Metastases by Inhibiting Heparanase and Interferon-γ-inducible Chemokines.
Topics: Animals; Chemokines; Colonic Neoplasms; Disease Models, Animal; Enoxaparin; Gene Expression Regulati | 2016 |
Health trends.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Blood Glucose; Bone Density Conservation Ag | 2010 |
Heparin treatment of malignancy: the case for clinical trials in colon cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Clinical Trials as Topic; Colonic Neoplasms; Disease Models | 2003 |
Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Bariatric Surgery; Colonic Neoplasms; Daltepar | 2010 |
Targeted chemoembolization of tumors with poly(2-hydroxyethyl methacrylate) particles.
Topics: Anticoagulants; Carcinoid Tumor; Chemoembolization, Therapeutic; Colonic Neoplasms; Dalteparin; Doxo | 2000 |
Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Chick Embryo; Chorioallantoic Membrane; Co | 2004 |